Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald H Tomkin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Expert Review of Cardiovascular Therapy|July 7, 2010
Atherosclerosis, diabetes and lipoproteinsGerald H Tomkin
Current Opinion in Molecular Therapeutics|October 7, 2009
Albiglutide, an albumin-based fusion of glucagon-like peptide 1 for the potential treatment of type 2 diabetesGerald H Tomkin
World Journal of Diabetes|October 16, 2014
Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitorsGerald H Tomkin
Atherosclerosis. Supplements|August 12, 2008
The intestine as a regulator of cholesterol homeostasis in diabetesGerald H Tomkin
British Journal of Pharmacology|September 16, 2009
Ezetimibe - new anti-atherogenic properties?Gerald H Tomkin
Atherosclerosis. Supplements|May 4, 2010
Dyslipidaemia--hepatic and intestinal cross-talkGerald H Tomkin
Diabetes Care|February 15, 2008
Targets for intervention in dyslipidemia in diabetesGerald H Tomkin
Current Opinion in Lipidology|December 25, 2008
The effect of antidiabetic drugs on genes regulating lipid metabolismGerald H Tomkin
Journal of Translational Internal Medicine|February 14, 2017
Obesity diabetes and the role of bile acids in metabolismGerald H Tomkin, Daphne Owens
World Journal of Diabetes|July 18, 2015
Dyslipidaemia of diabetes and the intestineGerald H Tomkin, Daphne Owens
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Review of Cardiovascular Therapy|July 7, 2010
Atherosclerosis, diabetes and lipoproteinsGerald H Tomkin
Current Opinion in Molecular Therapeutics|October 7, 2009
Albiglutide, an albumin-based fusion of glucagon-like peptide 1 for the potential treatment of type 2 diabetesGerald H Tomkin
World Journal of Diabetes|October 16, 2014
Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitorsGerald H Tomkin
Atherosclerosis. Supplements|August 12, 2008
The intestine as a regulator of cholesterol homeostasis in diabetesGerald H Tomkin
British Journal of Pharmacology|September 16, 2009
Ezetimibe - new anti-atherogenic properties?Gerald H Tomkin
Atherosclerosis. Supplements|May 4, 2010
Dyslipidaemia--hepatic and intestinal cross-talkGerald H Tomkin
Diabetes Care|February 15, 2008
Targets for intervention in dyslipidemia in diabetesGerald H Tomkin
Current Opinion in Lipidology|December 25, 2008
The effect of antidiabetic drugs on genes regulating lipid metabolismGerald H Tomkin
Journal of Translational Internal Medicine|February 14, 2017
Obesity diabetes and the role of bile acids in metabolismGerald H Tomkin, Daphne Owens
World Journal of Diabetes|July 18, 2015
Dyslipidaemia of diabetes and the intestineGerald H Tomkin, Daphne Owens
Pageof 2